CD83 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD83" in English language version.

refsWebsite

Global rank English rank

29nih.gov

4^th place

16doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1harvard.edu

18^th place

17^th place

1mallia.com

low place

1espacenet.com

800^th place

676^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Berchtold S, Jones T, Mühl-Zürbes P, Sheer D, Schuler G, Steinkasserer A (March 1999). "The human dendritic cell marker CD83 maps to chromosome 6p23". Annals of Human Genetics. 63 (Pt 2): 181–183. doi:10.1046/j.1469-1809.1999.6320181.x. PMID 10738529. S2CID 25338621.
Stein MF, Lang S, Winkler TH, Deinzer A, Erber S, Nettelbeck DM, et al. (April 2013). "Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells". Molecular and Cellular Biology. 33 (7): 1331–1344. doi:10.1128/MCB.01051-12. PMC 3624272. PMID 23339870.
Michalski J, Deinzer A, Stich L, Zinser E, Steinkasserer A, Knippertz I (July 2020). "Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells". Immunobiology. 225 (4) 151929. doi:10.1016/j.imbio.2020.151929. PMID 32115260.
Grosche L, Knippertz I, König C, Royzman D, Wild AB, Zinser E, et al. (17 April 2020). "The CD83 Molecule - An Important Immune Checkpoint". Frontiers in Immunology. 11 721. doi:10.3389/fimmu.2020.00721. PMC 7181454. PMID 32362900.
von Rohrscheidt J, Petrozziello E, Nedjic J, Federle C, Krzyzak L, Ploegh HL, et al. (August 2016). "Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83". The Journal of Experimental Medicine. 213 (9): 1685–1694. doi:10.1084/jem.20160316. PMC 4995086. PMID 27503071.
Bates JM, Flanagan K, Mo L, Ota N, Ding J, Ho S, et al. (March 2015). "Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis". Mucosal Immunology. 8 (2): 414–428. doi:10.1038/mi.2014.79. PMC 4326976. PMID 25204675.
Chen L, Zhu Y, Zhang G, Gao C, Zhong W, Zhang X (November 2011). "CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2". Proceedings of the National Academy of Sciences of the United States of America. 108 (46): 18778–18783. Bibcode:2011PNAS..10818778C. doi:10.1073/pnas.1018994108. PMC 3219128. PMID 22065790.
Wu YJ, Song YN, Geng XR, Ma F, Mo LH, Zhang XW, et al. (2020). "Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property". International Journal of Biological Sciences. 16 (2): 216–227. doi:10.7150/ijbs.38722. PMC 6949156. PMID 31929750.
Kadouri N, Nevo S, Goldfarb Y, Abramson J (April 2020). "Thymic epithelial cell heterogeneity: TEC by TEC". Nature Reviews. Immunology. 20 (4): 239–253. doi:10.1038/s41577-019-0238-0. PMID 31804611. S2CID 208622435.
Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, et al. (June 2018). "CD83 expression is essential for Treg cell differentiation and stability". JCI Insight. 3 (11) e99712. doi:10.1172/jci.insight.99712. PMC 6124443. PMID 29875316.
Maitra U, Davis S, Reilly CM, Li L (May 2009). "Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1". Journal of Immunology. 182 (9): 5763–5769. doi:10.4049/jimmunol.0900124. PMC 4773027. PMID 19380824.
Ishido S, Matsuki Y, Goto E, Kajikawa M, Ohmura-Hoshino M (March 2010). "MARCH-I: a new regulator of dendritic cell function". Molecules and Cells. 29 (3): 229–232. doi:10.1007/s10059-010-0051-x. PMID 20213309. S2CID 10403102.
Kretschmer B, Kühl S, Fleischer B, Breloer M (May 2011). "Activated T cells induce rapid CD83 expression on B cells by engagement of CD40". Immunology Letters. 136 (2): 221–227. doi:10.1016/j.imlet.2011.01.013. PMID 21277328.
Krzyzak L, Seitz C, Urbat A, Hutzler S, Ostalecki C, Gläsner J, et al. (May 2016). "CD83 Modulates B Cell Activation and Germinal Center Responses". Journal of Immunology. 196 (9): 3581–3594. doi:10.4049/jimmunol.1502163. PMID 26983787.
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, et al. (30 September 2022). "Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages". Frontiers in Immunology. 13 1012647. doi:10.3389/fimmu.2022.1012647. PMC 9564224. PMID 36248909.
Peckert-Maier K, Wild AB, Sprißler L, Fuchs M, Beck P, Auger JP, et al. (14 December 2023). "Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism". Frontiers in Immunology. 14 1293828. doi:10.3389/fimmu.2023.1293828. PMC 10755915. PMID 38162675.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000112149 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000015396 – Ensembl, May 2017

espacenet.com (Global: 800^th place; English: 676^th place)

worldwide.espacenet.com

EP patent 4135745, Alexander Steinkasserer, Elisabeth Zinser, Dmytro Royzman, "SCD83 for Wound Healing, Hair Growth, and Skin and Hair Care", issued 2025-05-07

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Chen L, Zhu Y, Zhang G, Gao C, Zhong W, Zhang X (November 2011). "CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2". Proceedings of the National Academy of Sciences of the United States of America. 108 (46): 18778–18783. Bibcode:2011PNAS..10818778C. doi:10.1073/pnas.1018994108. PMC 3219128. PMID 22065790.

mallia.com (Global: low place; English: low place)

"Our Science: Therapeutics". Mallia Therapeutics. Retrieved 27 January 2026.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Berchtold S, Jones T, Mühl-Zürbes P, Sheer D, Schuler G, Steinkasserer A (March 1999). "The human dendritic cell marker CD83 maps to chromosome 6p23". Annals of Human Genetics. 63 (Pt 2): 181–183. doi:10.1046/j.1469-1809.1999.6320181.x. PMID 10738529. S2CID 25338621.
Stein MF, Lang S, Winkler TH, Deinzer A, Erber S, Nettelbeck DM, et al. (April 2013). "Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells". Molecular and Cellular Biology. 33 (7): 1331–1344. doi:10.1128/MCB.01051-12. PMC 3624272. PMID 23339870.
Michalski J, Deinzer A, Stich L, Zinser E, Steinkasserer A, Knippertz I (July 2020). "Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells". Immunobiology. 225 (4) 151929. doi:10.1016/j.imbio.2020.151929. PMID 32115260.
Grosche L, Knippertz I, König C, Royzman D, Wild AB, Zinser E, et al. (17 April 2020). "The CD83 Molecule - An Important Immune Checkpoint". Frontiers in Immunology. 11 721. doi:10.3389/fimmu.2020.00721. PMC 7181454. PMID 32362900.
von Rohrscheidt J, Petrozziello E, Nedjic J, Federle C, Krzyzak L, Ploegh HL, et al. (August 2016). "Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83". The Journal of Experimental Medicine. 213 (9): 1685–1694. doi:10.1084/jem.20160316. PMC 4995086. PMID 27503071.
Bates JM, Flanagan K, Mo L, Ota N, Ding J, Ho S, et al. (March 2015). "Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis". Mucosal Immunology. 8 (2): 414–428. doi:10.1038/mi.2014.79. PMC 4326976. PMID 25204675.
Chen L, Zhu Y, Zhang G, Gao C, Zhong W, Zhang X (November 2011). "CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2". Proceedings of the National Academy of Sciences of the United States of America. 108 (46): 18778–18783. Bibcode:2011PNAS..10818778C. doi:10.1073/pnas.1018994108. PMC 3219128. PMID 22065790.
Wu YJ, Song YN, Geng XR, Ma F, Mo LH, Zhang XW, et al. (2020). "Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property". International Journal of Biological Sciences. 16 (2): 216–227. doi:10.7150/ijbs.38722. PMC 6949156. PMID 31929750.
Kadouri N, Nevo S, Goldfarb Y, Abramson J (April 2020). "Thymic epithelial cell heterogeneity: TEC by TEC". Nature Reviews. Immunology. 20 (4): 239–253. doi:10.1038/s41577-019-0238-0. PMID 31804611. S2CID 208622435.
Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, et al. (June 2018). "CD83 expression is essential for Treg cell differentiation and stability". JCI Insight. 3 (11) e99712. doi:10.1172/jci.insight.99712. PMC 6124443. PMID 29875316.
Maitra U, Davis S, Reilly CM, Li L (May 2009). "Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1". Journal of Immunology. 182 (9): 5763–5769. doi:10.4049/jimmunol.0900124. PMC 4773027. PMID 19380824.
Ishido S, Matsuki Y, Goto E, Kajikawa M, Ohmura-Hoshino M (March 2010). "MARCH-I: a new regulator of dendritic cell function". Molecules and Cells. 29 (3): 229–232. doi:10.1007/s10059-010-0051-x. PMID 20213309. S2CID 10403102.
Kretschmer B, Kühl S, Fleischer B, Breloer M (May 2011). "Activated T cells induce rapid CD83 expression on B cells by engagement of CD40". Immunology Letters. 136 (2): 221–227. doi:10.1016/j.imlet.2011.01.013. PMID 21277328.
Krzyzak L, Seitz C, Urbat A, Hutzler S, Ostalecki C, Gläsner J, et al. (May 2016). "CD83 Modulates B Cell Activation and Germinal Center Responses". Journal of Immunology. 196 (9): 3581–3594. doi:10.4049/jimmunol.1502163. PMID 26983787.
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, et al. (30 September 2022). "Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages". Frontiers in Immunology. 13 1012647. doi:10.3389/fimmu.2022.1012647. PMC 9564224. PMID 36248909.
Peckert-Maier K, Wild AB, Sprißler L, Fuchs M, Beck P, Auger JP, et al. (14 December 2023). "Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism". Frontiers in Immunology. 14 1293828. doi:10.3389/fimmu.2023.1293828. PMC 10755915. PMID 38162675.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: CD83 CD83 molecule".
Stein MF, Lang S, Winkler TH, Deinzer A, Erber S, Nettelbeck DM, et al. (April 2013). "Multiple interferon regulatory factor and NF-κB sites cooperate in mediating cell-type- and maturation-specific activation of the human CD83 promoter in dendritic cells". Molecular and Cellular Biology. 33 (7): 1331–1344. doi:10.1128/MCB.01051-12. PMC 3624272. PMID 23339870.
Grosche L, Knippertz I, König C, Royzman D, Wild AB, Zinser E, et al. (17 April 2020). "The CD83 Molecule - An Important Immune Checkpoint". Frontiers in Immunology. 11 721. doi:10.3389/fimmu.2020.00721. PMC 7181454. PMID 32362900.
von Rohrscheidt J, Petrozziello E, Nedjic J, Federle C, Krzyzak L, Ploegh HL, et al. (August 2016). "Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83". The Journal of Experimental Medicine. 213 (9): 1685–1694. doi:10.1084/jem.20160316. PMC 4995086. PMID 27503071.
Bates JM, Flanagan K, Mo L, Ota N, Ding J, Ho S, et al. (March 2015). "Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis". Mucosal Immunology. 8 (2): 414–428. doi:10.1038/mi.2014.79. PMC 4326976. PMID 25204675.
Chen L, Zhu Y, Zhang G, Gao C, Zhong W, Zhang X (November 2011). "CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2". Proceedings of the National Academy of Sciences of the United States of America. 108 (46): 18778–18783. Bibcode:2011PNAS..10818778C. doi:10.1073/pnas.1018994108. PMC 3219128. PMID 22065790.
Wu YJ, Song YN, Geng XR, Ma F, Mo LH, Zhang XW, et al. (2020). "Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property". International Journal of Biological Sciences. 16 (2): 216–227. doi:10.7150/ijbs.38722. PMC 6949156. PMID 31929750.
Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, et al. (June 2018). "CD83 expression is essential for Treg cell differentiation and stability". JCI Insight. 3 (11) e99712. doi:10.1172/jci.insight.99712. PMC 6124443. PMID 29875316.
Maitra U, Davis S, Reilly CM, Li L (May 2009). "Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1". Journal of Immunology. 182 (9): 5763–5769. doi:10.4049/jimmunol.0900124. PMC 4773027. PMID 19380824.
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, et al. (30 September 2022). "Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages". Frontiers in Immunology. 13 1012647. doi:10.3389/fimmu.2022.1012647. PMC 9564224. PMID 36248909.
Peckert-Maier K, Wild AB, Sprißler L, Fuchs M, Beck P, Auger JP, et al. (14 December 2023). "Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism". Frontiers in Immunology. 14 1293828. doi:10.3389/fimmu.2023.1293828. PMC 10755915. PMID 38162675.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Berchtold S, Jones T, Mühl-Zürbes P, Sheer D, Schuler G, Steinkasserer A (March 1999). "The human dendritic cell marker CD83 maps to chromosome 6p23". Annals of Human Genetics. 63 (Pt 2): 181–183. doi:10.1046/j.1469-1809.1999.6320181.x. PMID 10738529. S2CID 25338621.
Kadouri N, Nevo S, Goldfarb Y, Abramson J (April 2020). "Thymic epithelial cell heterogeneity: TEC by TEC". Nature Reviews. Immunology. 20 (4): 239–253. doi:10.1038/s41577-019-0238-0. PMID 31804611. S2CID 208622435.
Ishido S, Matsuki Y, Goto E, Kajikawa M, Ohmura-Hoshino M (March 2010). "MARCH-I: a new regulator of dendritic cell function". Molecules and Cells. 29 (3): 229–232. doi:10.1007/s10059-010-0051-x. PMID 20213309. S2CID 10403102.